Malignant fibrous histiocytoma of the eyelid: Differential diagnosis and management

Ophthalmic Plastic and Reconstructive Surgery

Volumn 21, Issue 2, 2005, Pages 103-108

  Khong, Jwu Jin ^a   Chen, Celia S ^a   James, Craig L ^b   Huilgol, Shyamala C ^a   O'Donnell, Brett A ^c   Sullivan, Timothy J ^d   Selva, Dinesh ^a,e  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Adelaide Pathology Partners   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CLINICAL ARTICLE; DERMATOFIBROMA; DIFFERENTIAL DIAGNOSIS; EYELID TUMOR; FEMALE; FIBROXANTHOMA; HISTOLOGY; HUMAN; LEIOMYOSARCOMA; LYMPH NODE METASTASIS; MALE; PATHOLOGY; PRIORITY JOURNAL; REVIEW;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; EYELID NEOPLASMS; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; OPHTHALMOLOGIC SURGICAL PROCEDURES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 15944400591     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.IOP.0000155858.52464.6F     Document Type: Review

References (41)

1. Font RL, Hidayat AA. Fibrous histiocytoma of the orbit: a clinicopathologic study of 150 cases. Hum Pathol 1982;13:199-209.
2. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978;41:2250-66.
3. Cole CH, Magee TF, Gianoulis M, et al. Malignant fibrous histiocytoma in childhood. Cancer 1993;71:4077-83.
4. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma. Cancer 1979;44:2147.
5. Weiss SW, Goldblum JR. Malignant fibrohistiocytic tumours. In: Weiss SW, ed. Enzinger and Weiss's Soft Tissue Tumours. 4th edition. St. Louis: Mosby, 2000, pp 351-80.
6. Ozello L, Stout AP, Murray MR. Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 1963;16:331.
7. O'Brien JE, Stout AP. Malignant fibrous xanthoma. Cancer 1964;17:1445.
8. Vogel MH. Fibrous xanthoma of the orbit. Klin monastsbl augenheilkd 1969;155:552-8.
9. Verity MA, Ebert JT, Hepler RS. Atypical fibrous histiocytoma of the orbit: an electron microscopic study. Ophthalmologica 1977;175:73-9.
10. Rodrigues MM, Furgiuele FP, Weinreb S. Malignant fibrous histiocytoma of the orbit. Arch Ophthalmol 1977;95:2025-8.
11. Biedner B, Rothkoff L. Orbital fibrous histiocytoma in an infant. Am J Ophthalmol 1978;85:548-50.
12. Roth AM. Malignant fibrous histiocytoma of the ocular adnexa. Metab Pediatr Syst Ophthalmol 1993;16:5-8.
13. Nath R, Saxena S, Agarwal PK, et al. Angiomatoid malignant fibrous histiocytoma of the eyelid. Indian J Ophthalmol 1992;40:63-5.
14. Boynton JR, Markowitch WJ, Searl SS, et al. Periocular malignant fibrous histiocytoma. Ophthalmol Plast Reconstr Surg 1989;5:239-46.
15. Rossi P, Ducasse A, Pluot M, et al. Malignant fibrous histiocytoma of the eyelid. J Fr Ophtalmol 2002;25:1036-42.
16. Ko JY, Chen CL, Lui L, et al. Radiation-induced malignant fibrous histiocytoma in patients with nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 1996;122:535-8.
17. Shields JA, Husson M, Shields CL, et al. Orbital malignant fibrous histiocytoma following irradiation for retinoblastoma. Ophthalmol Plast Reconstr Surg 2001;17:58-61.
18. Fletcher CDM, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 2001;19:3045-50.
19. Brinck U, Korabiowska M, Buschmann N, et al. Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytoma. Anticancer Res 1999;19:5211-6.
20. Ludemann M, Fischer A, Finke M, et al. Molecular biological observations in some rare neoplasms: DNA ploidy and cell cycle data in liposarcoma and malignant fibrous histiocytoma. Langenbecks Arch Surg 1999;384:209-15.
21. Okita H, Ohtsuka T, Yamazaki S. Flow-cytometric DNA analysis in cutaneous fibrohistiocytic tumors. Dermatology 2003;207:357-61.
22. Lazova R, Moynes R, May D, Scott G. LN-2 (CD 74) A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer 1997;79:2115-24.
23. Skoulas IG, Price M, Andrew JE, et al. Recurrent atypical fibroxanthoma of the cheek. Am J Otolaryngol 2001;22:73-5.
24. Rizzardi C, Angiero F, Melato M. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin. Anticancer Res 2003;23:1847-51.
25. Hayami J, Kurokawa I, Hashimoto K, et al. Malignant fibrous histiocytoma of scalp with intracranial invasion 20 years after postoperative irradiation. J Craniofac Surg 2003;14:74-7.
26. Huntington AC, Langloss JM, Hidayat AA. Spindle cell carcinoma of conjunctiva: an immunohistochemical and ultrastructural study of six cases. Ophthalmology 1990;97:711-7.
27. Belal A, Kandil A, Allam A, et al. Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol 2002;25:16-22.
28. Stojadinovic A, Leung DHY, Hoos A, et al. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg 2002;235:424-34.
29. Rööser B, Willén H, Gustafson P, et al. Malignant fibrous histiocytoma of soft tissue: a population -based epidemiologic and prognostic study of 137 patients. Cancer 1991;67:499-505.
30. Matsumoto S, Ahmed AR, Kawaguchi N, et al. Results of surgery for malignant fibrous histiocytomas of soft tissue. Int J Clin Oncol 2003;8:104-9.
31. Flugstad DL, Wilke CP, McNutt MA, et al. Importance of surgical resection in the successful management of soft tissue sarcoma. Arch Surg 1999;134:856-62.
32. Huether MJ, Zitelli JA, Brodland DG. Mohs microsurgery for the treatment of cutaneous spindle cell tumors of the skin. J Am Acad Dermatol 2001;44:656-9.
33. Hafner J, Schutz K, Morgenthaler W, et al. Micrographic surgery ('slow Mohs') in cutaneous sarcomas. Dermatology 1999;198:37-43.
34. Fish FS. Soft tissue sarcomas in dermatology. Dermatol Surg 1996;22:268-73.
35. Wilson RB, Crowe PJ, Fisher R, et al. Extremity soft tissue sarcoma: factors predictive of local recurrence and survival. Aust N Z J Surg 1999;69:344-9.
36. Mann GB, Lewis JJ, Brennan MF. Adult soft tissue sarcoma. Aust N Z J Surg 1999;69:336-43.
37. Choong PFM, Petersen IA, Nascimento AG, et al. Is radiotherapy important for low-grade soft tissue sarcoma of the extremity? Clin Orthop 2001;1:191-9.
38. Henshaw RM, Priebat DA, Perry DJ, et al. Survival after induction chemotherapy and surgical resection for high grade soft tissue sarcoma. Is radiation necessary? Ann Surg Oncol 2001;8:484-95.
39. Frustaci S, Gherlinzoni F, Paoli AD, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001;19:1238-47.
40. Pezzi CM, Rawlings MS, Esgro JJ, et al. Prognostic factors in 227 patients with malignant fibrous histiocytoma. Cancer 1992;69:2098-103.
41. Le Doussal V, Coindre JM, Leroux A, et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer 1996;77:1823-30.